https://www.selleckchem.com/products/exarafenib.html With regard to the IP diagnosis in the IP and NP group based on the SCCA level (>1.5ng/ml), sensitivity and specificity was 80.0% and 93.3%, respectively. The serum SCCA level in patients with IP was elevated and then it decreased after surgery. This was different from NP and rhinitis patients who mostly had normal levels, which did not change. The serum SCCA level in patients with IP was elevated and then it decreased after surgery. This was different from NP and rhinitis patients who mostly had normal levels, which did not change. The size of the cochlea varies a lot among the human population bringing the necessity for electrode arrays to be available in various lengths irrespective of the cochlear implant (CI) brand. This research software helps in the estimation of the patient's cochlear duct length (CDL) which is then used for the simulation of the correct length electrode array matching the patient's cochlear size and as well in getting the patient specific cochlear frequency map. Visual Studio Express 2012 for Windows Desktop is used in the architecture of this research software. The basal turn diameter of the cochlea ("A" value) needs to be measured from the pre-operative computed tomography (CT) image of the patient's temporal bone. This "A" will be taken as the input for the CDL equations proposed by Alexiades etal for estimating the CDL along the basilar membrane for various insertion depths. Greenwood's equation is then used in combination with the CDL for the full length of the cochlea in getting the patient specific frecific cochlear frequency map. The clinicians get the chance to simulate placing the various electrode array lengths in patient cochlea in identifying the best fit electrode. This could help in pushing the CI field into the concept of individualized CI electrode array solution that ultimately benefits the patients. To determine anatomic relationships and variation of the round window m